针刺十三鬼穴联合醒脑静治疗重症昏迷的临床观察

Clinical Observation of Acupuncture at the Thirteen Ghost Acupoints plus Xingnaojing for Severe Coma

目的观察针刺十三鬼穴联合醒脑静治疗重症昏迷的临床疗效。方法 60例重症脑昏迷患者随机分为试验组和对照组,每组30例。两组均给予基础治疗,试验组给予针刺十三鬼穴联合醒脑静治疗,对照组给予醒脑静治疗。观察两组治疗前后格拉斯哥昏迷量表(GCS)评分变化,比较两组意识苏醒时间及并发症的发生率。结果试验组在治疗4周后、8周后的GCS评分为(7.57±0.88)分和(11.63±1.33)分,并发症的发生率为33.3%和6.7%,平均意识苏醒时间为(4.67±1.07)d;对照组的GCS评分为(7.50±1.09)分和(10.40±1.14)分,并发症的发生率为33.3%和13.3%,平均意识苏醒时间为(5.87±0.81)d。两组治疗4周后GCS评分比较差异无统计学意义(P>0.05),治疗8周后GCS评分、并发症的发生率、平均意识苏醒时间比较差异有统计学意义(P<0.01)。结论使用针刺十三鬼穴联合醒脑静治疗重症昏迷患者优于醒脑静治疗,值得临床应用。

Objective To observe the clinical efficacy of acupuncture at the thirteen ghost acupoints plus Xingnaojing in treating severe coma.Method Sixty patients in severe coma were randomized into an experimental group and a control group,with 30 cases in each group.The two groups were both given basic intervention.In addition,the experimental group was intervened by acupuncture at the thirteen ghost acupoints plus Xingnaojing,while the control group was prescribed with Xingnaojing alone.The two groups were observed using the Glasgow Coma Scale(GCS)before and after treatment.The consciousness recovery time and occurrence rate of complications were also compared between the two groups.Result In the experimental group,The GCS score was(7.57±0.88)points and(11.63±1.33)points respectively after 4-week and 8-week treatment,the occurrence rate of complications was 33.3%and 6.7%,and the mean consciousness recovery time was(4.67±1.07)d.in the control group,the GCS score was(7.50±1.09)points and(10.40±1.14)points,the occurrence rate of complications was 33.3%and 13.3%,and the mean consciousness recovery time was(5.87±0.81)d.There was no significant difference in the GCS score after 4-week treatment between the two groups(P>0.05);the between-group differences were statistically significant comparing the GCS score,the occurrence rate of complications and mean consciousness recovery time after 8-week treatment(P<0.01).Conclusion Acupuncture at the thirteen ghost acupoints plus Xingnaojing can produce more significant efficacy than Xingnaojing alone in treating severe coma patients,and is worth promoting in clinic.